# US 2008/0188529 A1 · Cathepsin cysteine protease inhibitors

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0188529 A1
- Document ID: US20080188529A1
- Status: Published application
- Kind: A1
- Application number: 12/082,104
- Filed: 2008-04-08
- Published: 2008-08-07
- Earliest claimed: 2002-03-05
- Assignees: Axys Pharmaceuticals, Inc.; Merck Canada Inc.
- Inventors: Christopher I. Bayly; Cameron Black; Serge Leger; Chun Sing Li; Dan McKay; Christophe Mellon; Jacques Yves Gauthier; Vouy-Linh Truong; Cheuk Lau; Michel Therien; Michael J. Green; Bernard L. Hirschbein; James William Janc; James T. Palmer; Chitra Baskaran
- Web page: https://patentgrep.com/patent/US20080188529A1

## CPC

- A61P 1/02: Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- C07C 237/20: the carbon skeleton containing six-membered aromatic rings
- A61K 31/165: having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K 31/18: Sulfonamides (compounds containing a para-N-benzene-sulfonyl-N- group A61K31/63)
- A61K 31/4174: Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
- A61K 31/426: 1,3-Thiazoles
- A61K 31/44: Non condensed pyridines; Hydrogenated derivatives thereof
- A61K 31/4418: having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
- A61K 31/495: having six-membered rings with two {or more} nitrogen atoms as the only ring heteroatoms, e.g. piperazine {or tetrazines}(A61K31/48 takes precedence {; with three nitrogen atoms A61K31/53})
- A61P 3/14: for calcium homeostasis (vitamin D A61P3/02; parathyroid hormones A61P5/18; calcitonin A61P5/22; osteoporosis A61P19/10; bone metastasis A61P35/04)
- A61P 19/00: Drugs for skeletal disorders
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 19/04: for non-specific disorders of the connective tissue
- A61P 19/06: Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A61P 19/08: for bone diseases, e.g. rachitism, Paget's disease
- A61P 19/10: for osteoporosis
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 35/00: Antineoplastic agents
- A61P 35/04: specific for metastasis
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07C 255/25: Aminoacetonitriles
- C07C 255/29: containing cyano groups and acylated amino groups bound to the carbon skeleton
- C07C 255/46: to carbon atoms of non-condensed rings
- C07C 255/58: containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
- C07C 259/10: having carbon atoms of hydroxamic groups bound to carbon atoms of six-membered aromatic rings
- C07C 311/37: having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- C07C 317/32: with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07D 209/08: with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
- C07D 213/38: having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
- C07D 213/57: Nitriles
- C07D 213/64: attached in position 2 or 6
- C07D 213/70: Sulfur atoms
- C07D 213/89: with hetero atoms directly attached to the ring nitrogen atom
- C07D 215/12: with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D 231/12: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D 233/64: with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
- C07D 239/26: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D 241/12: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D 261/08: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D 263/32: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D 271/06: 1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
- C07D 277/28: Radicals substituted by nitrogen atoms
- C07D 277/30: Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D 295/135: with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
- C07D 295/155: with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
- C07D 307/52: Radicals substituted by nitrogen atoms not forming part of a nitro radical
- C07D 333/20: by nitrogen atoms (nitro, nitroso radicals C07D333/12)
- C07D 401/04: directly linked by a ring-member-to-ring-member bond
- C07D 417/04: directly linked by a ring-member-to-ring-member bond
- C07C 2601/02: with a three-membered ring
- C07C 2601/14: The ring being saturated
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.

## Claims

### Claim 1

A compound of the following chemical formula:
wherein
R1 is hydrogen or C1-6 alkyl
R2 is hydrogen or C1-6 alkyl
or R1 and R2 can be taken together with the carbon atom to which they are attached to form a C3-8 cycloalkyl ring;
R3 is C1-6 alkyl wherein said alkyl group is optionally substituted with one to six halo;
R4 is hydrogen;
R5 is hydrogen;
R6 is C1-6 haloalkyl;
each D is independently aryl or heteroaryl, wherein each said aryl or heteroaryl, is optionally substituted on either the carbon or the heteroatom with one to five substituents independently selected from C1-6 alkyl, haloalkyl or halo;
R7 is hydrogen, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 alkyloxy, halo, cyano, C3-8 cycloalkyl, heterocyclyl, C(R10)(R11)OH, —SR12, —SR9, SO(R12), —SOmN(Rc)(Rd), —SO2N(R10)C(O)(R12), N(R10)(R11), N(R10)CO(R9), —N(R10)C(O)R10, —N(R10)SO2(R10); wherein said groups are optionally substituted on either the carbon or the heteroatom with one to five substituents independently selected from C1-6 alkyl, halo, haloalkyl, hydroxyalkyl, —OR9, —NHS(O)2R8, —R9SO2R12, —SO2R12, —SO(R12), —SR12, —SR9, —SOmN(Rc)(Rd), —C(R10)(R11)OH, —COOH, N(R10)CO(R9), heterocycyl, aryl or heteroaryl;
R8 is hydrogen;
R9 is selected from the group consisting of hydrogen, aryl, aryl(C1-4)alkyl, heteroaryl, heteroaryl(C1-4)alkyl, C3-8cycloalkyl, C3-8cycloalkyl(C1-4)alkyl, and heterocyclyl(C1-4)alkyl wherein said groups can be optionally substituted with one, two, or three substituents independently selected from halo, alkoxy or —SO2R12;
R10 is hydrogen or C1-6 alkyl
R11 is hydrogen or C1-6 alkyl;
R12 is hydrogen or C1-6 alkyl which is optionally substituted with one, two, or three substituents independently selected from halo, alkoxy, cyano, —NR10 or —SR10;
Rc is hydrogen or C1-6 alkyl which is optionally substituted with one, two, or three substituents independently selected from halo or —OR9;
Rd is hydrogen or C1-6 alkyl which is optionally substituted with one, two, or three substituents independently selected from halo or —OR9;
or Rc and Rd can be taken together with the nitrogen atom to which they are attached or are between them to form a C3-8 heterocyclyl ring which is optionally substituted with one or two substituents independently selected from C1-6 alkyl, halo hydroxyalkyl, hydroxy, alkoxy or keto;
n is independently selected from an integer from one to two;
each m is independently selected from an integer from zero to one;
and the pharmaceutically acceptable salts, stereoisomers and N-oxide derivatives thereof.

### Claim 2 (depends on 1)

The compound of claim 1 wherein R1 is hydrogen and R2 is hydrogen, or R1 and R2 can be taken together with the carbon atom to which they are attached to form a C3-8 cycloalkyl ring, and the pharmaceutically acceptable salts, stereoisomers and N-oxide derivatives thereof.

### Claim 3

(canceled)

### Claim 4 (depends on 4)

The compound of claim 4, wherein R3 is n-propyl, isobutyl, 2-fluoro-2-methylpropyl, 2-trifluoromethylpropyl, 3-fluoro-2-(2-fluoromethyl)propyl, 2,2-difluoroethyl, 2,2-difluoropropyl, 3,3,3-trifluoropropyl, or 2,2-dichloroethyl and R4 is hydrogen; and the pharmaceutically acceptable salts, stereoisomers and N-oxide derivatives thereof.

### Claim 5

(canceled)

### Claim 6

(canceled)

### Claim 7 (depends on 4)

The compound of claim 4 wherein R5 is hydrogen and R6 is trifluoromethyl or 3,3,3,2,2-pentafluoroethyl; and the pharmaceutically acceptable salts, stereoisomers and N-oxide derivatives thereof.

### Claim 8

(canceled)

### Claim 9 (depends on 1)

The compound of claim 1 selected from:
N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide;
N1-(cyanomethyl)-N2-[2,2,2-trifluoro-1-(4-fluoro-3-methylphenyl)ethyl]-L-leucinamide;
N1-(cyanomethyl)-N2-[(1R)-2,2,2-trifluoro-1-(4-pyridin-3-ylphenyl)ethyl]-L-leucinamide;
N1-(cyanomethyl)-N2-[(1S)-2,2,2-trifluoro-1-(4-pyridin-3-ylphenyl)ethyl]-L-leucinamide;
N1-(cyanomethyl)-N2-[(1R)-2,2,2-trifluoro-1-(4-pyridin-4-ylphenyl)ethyl]-L-leucinamide;
N1-(cyanomethyl)-N2-[(1S)-2,2,2-trifluoro-1-(4-pyridin-4-ylphenyl)ethyl]-L-leucinamide;
N2-[1-(1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-N1-(cyanomethyl)-L-leucinamide;
N1-(cyanomethyl)-N2-{2,2,2-trifluoro-1-[4-(3-hydroxy-3-methylbut-1-ynyl)phenyl]ethyl}-L-leucinamide;
N1-(cyanomethyl)-N2-{(1S)-2,2,2-trifluoro-1-[4-(3-hydroxy-3-methylbutyl)phenyl]ethyl}-L-leucinamide;
N2-[(1S)-1-(4-bromophenyl)-2,2,3,3,3-pentafluoropropyl]-N1-(cyanomethyl)-L-leucinamide;
N1-(cyanomethyl)-N2-[(1S)-2,2,3,3,3-pentafluoro-1-(4-pyridin-4-ylphenyl)propyl]-L-leucinamide;
N1-(cyanomethyl)-N2-[(1S)-2,2,2-trifluoro-1-(4′-fluoro-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;
N1-(cyanomethyl)-N2-((1S)-2,2,2-trifluoro-1-{4-[(1E)-3-hydroxy-3-methylbut-1-enyl]phenyl}ethyl)-L-leucinamide;
N1-(cyanomethyl)-N2-{(1S)-2,2,3,3,3-pentafluoro-1-[4′-(methylthio)-1,1′-biphenyl-4-yl]propyl}-L-leucinamide;
N1-(cyanomethyl)-N2-{(1S)-2,2,2-trifluoro-1-[4-(morpholin-4-ylcarbonyl)phenyl]ethyl}-L-leucinamide;
N1-(cyanomethyl)-N2-[(1S)-2,2,2-trifluoro-1-(4-thien-3-ylphenyl)ethyl]-L-leucinamide;
N1-(cyanomethyl)-N2-{(1S)-2,2,2-trifluoro-1-[4-(4-methylpyridin-2-yl)phenyl]ethyl}-L-leucinamide;
N1-(cyanomethyl)-N2-{(1S)-2,2,2-trifluoro-1-[4-(5-methylpyridin-2-yl)phenyl]ethyl}-L-leucinamide;
N1-(cyanomethyl)-N2-[(1S)-2,2,2-trifluoro-1-(2′-fluoro-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;
N1-(cyanomethyl)-N2-{(1S)-1-[4-(3,5-dimethylisoxazol-4-yl)phenyl]-2,2,2-trifluoroethyl}-L-leucinamide;
N1-(cyanomethyl)-N2-{(1S)-2,2,2-trifluoro-1-[4′-(hydroxymethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
N2-[(1S)-1-(4′-cyano-1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-N1-(cyanomethyl)-L-leucinamide;
N1-(cyanomethyl)-N2-[(1S)-1-(3′,4′-difluoro-1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-L-leucinamide;
N1-(cyanomethyl)-N2-[(1S)-1-(3′,4′-dimethoxy-1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-L-leucinamide;
N1-(cyanomethyl)-N2-{(1S)-2,2,2-trifluoro-1-[2′-(trifluoromethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
N1-(cyanomethyl)-N2-[(1S)-1-(3′,4′-dichloro-1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-L-leucinamide;
N2-{(1S)-1-[4-(5-bromopyridin-3-yl)phenyl]-2,2,2-trifluoroethyl}-N1-(cyanomethyl)-L-leucinamide;
N1-(cyanomethyl)-N2-{(1S)-2,2,2-trifluoro-1-[4′-(trifluoromethoxy)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
N1-(cyanomethyl)-N2-[(1S)-2,2,2-trifluoro-1-(4-pyrimidin-5-ylphenyl)ethyl]-L-leucinamide;
N1-(cyanomethyl)-N2-{1(1S)-2,2,2-trifluoro-1-[4-(1,3-thiazol-2-yl)phenyl]ethyl}-L-leucinamide;
4′-{1-[1-(Cyanomethyl-carbamoyl)-3-methyl-butylamino]-2,2,2-trifluoro-ethyl}-biphenyl-4-carboxylic acid methyl ester;
N1-(cyanomethyl)-N2-[(1S)-2,2,2-trifluoro-1-(4-pyrimidin-2-ylphenyl)ethyl]-L-leucinamide;
N1-(cyanomethyl)-N2-{(1S)-2,2,2-trifluoro-1-[4-(3-methylpyridin-2-yl)phenyl]ethyl}-L-leucinamide;
N1-(cyanomethyl)-N2-{(1S)-2,2,2-trifluoro-1-[4-(3-furyl)phenyl]ethyl}-L-leucinamide;
N1-(cyanomethyl)-N2-((1S)-2,2,2-trifluoro-1-{4-[3-(trifluoromethyl)pyridin-2-yl]phenyl}ethyl)-L-leucinamide;
N1-(cyanomethyl)-N2-((1S)-2,2,2-trifluoro-1-{4-[4-(trifluoromethyl)pyridin-2-yl]phenyl}ethyl)-L-leucinamide;
N1-(cyanomethyl)-N2-((1S)-2,2,2-trifluoro-1-{4-[5-(trifluoromethyl)pyridin-2-yl]phenyl}ethyl)-L-leucinamide;
N1-(cyanomethyl)-N2-[(1S)-2,2,2-trifluoro-1-(3′-methoxy-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;
N2-{(1S)-1-[4′-(acetylamino)-3′-fluoro-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-N1-(cyanomethyl)-L-leucinamide;
N1-(cyanomethyl)-N2-{(1S)-2,2,2-trifluoro-1-[4-(3-methylthien-2-yl)phenyl]ethyl}-L-leucinamide;
N1-(cyanomethyl)-N2-[(1S)-2,2,2-trifluoro-1-(3′-fluoro-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;
N1-(cyanomethyl)-N2-{(1S)-2,2,2-trifluoro-1-[3′-(trifluoromethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
N1-(cyanomethyl)-N2-[(1S)-2,2,2-trifluoro-1-(5′-fluoro-2′-methoxy-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;
N1-(cyanomethyl)-N2-[(1S)-1-(3′,5′-difluoro-1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-L-leucinamide;
N1-(cyanomethyl)-N2-[(1S)-2,2,2-trifluoro-1-(2′,3′,5′-trifluoro-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;
3-(4′-{1-[1-(Cyanomethyl-carbamoyl)-3-methyl-butylamino]-2,2,2-trifluoro-ethyl}-biphenyl-3-yl)-acrylic acid;
N1-(cyanomethyl)-N2-{2,2,2-trifluoro-1-[4′-(methylsulfinyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
N1-(cyanomethyl)-N2-[2,2,2-trifluoro-1-(4-morpholin-4-ylphenyl)ethyl]-L-leucinamide;
N1-(cyanomethyl)-N2-(R)-2,2,2-trifluoro-1-[4-(6-methylpyridin-3-yl)phenyl]ethyl-L-leucinamide;
N1-(cyanomethyl)-N2-{(S)-2,2,2-trifluoro-1-[4-(6-methylpyridin-3-yl)phenyl]ethyl}-L-leucinamide;
N1-(cyanomethyl)-N2-[2,2,2-trifluoro-1-(5-phenylthien-2-yl)ethyl]-L-leucinamide;
N1-(cyanomethyl)-N2-[(1S)-2,2,2-trifluoro-1-(4-pyridin-2-ylphenyl)ethyl]-L-leucinamide;
N2-{1-[4′-(aminosulfonyl)-1,1′-biphenyl-4-yl]-2,2,2-trifluoro ethyl}-N1-(cyanomethyl)-L-leucinamide;
N2-{(1S)-1-[4′-(aminosulfonyl)-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-N1-(cyanomethyl)-L-leucinamide;
N1-(cyanomethyl)-N2-{(1S)-2,2,2-trifluoro-1-[4′-(methylthio)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
N2-[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N1-(cyanomethyl)-L-leucinamide;
N1-(cyanomethyl)-N2-{(1S)-2,2,2-trifluoro-1-[4′-(morpholin-4-ylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
N2-{(1S)-1-[4′-(aminosulfonyl)-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-N1-(cyanomethyl)-L-leucinamide;
N2-((1S)-1-{4′-[(acetylamino)sulfonyl]-1,1′-biphenyl-4-yl}-2,2,2-trifluoroethyl)-N1-(cyanomethyl)-L-leucinamide;
N2-[1-(5-bromothien-2-yl)-2,2,2-trifluoroethyl]-N1-(cyanomethyl)-L-leucinamide;
N2-[1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N1-(cyanomethyl)-L-leucinamide;
N1-(cyanomethyl)-N2-[2,2,2-trifluoro-1-(4′-piperazin-1-yl-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;
N1-(cyanomethyl)-N2-[2,2,2-trifluoro-1-(4′-piperazin-1-yl-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;
N1-(cyanomethyl)-N2-{(1S)-2,2,2-trifluoro-11-[4-(2-methyl-1,3-thiazol-4-yl)phenyl]ethyl)}-L-leucinamide;
N2-{1-[4-(3-tert-butyl-1,2,4-triazin-5-yl)phenyl]-2,2,2-trifluoroethyl}-N1-(cyanomethyl)-L-leucinamide;
N1-(cyanomethyl)-N2-((1S)-2,2,2-trifluoro-1-{4-[2-(1H-pyrazol-4-yl)-1,3-thiazol-4-yl]phenyl}ethyl)-L-leucinamide;
N2-[1-(3-bromophenyl)-2,2,2-trifluoroethyl]-N1-(cyanomethyl)-L-leucinamide;
N1-(cyanomethyl)-N2-{2,2,2-trifluoro-1-[4′-(methylthio)-1,1′-biphenyl-3-yl]ethyl}-L-leucinamide;
N1-(cyanomethyl)-N2-[2,2,2-trifluoro-1-(3-pyridin-4-ylphenyl)ethyl]-L-leucinamide;
N1-(cyanomethyl)-N2-[2,2,2-trifluoro-1-(4′-piperazin-1-yl-1,1′-biphenyl-3-yl)ethyl]-L-leucinamide;
N1-(cyanomethyl)-N2-[2,2,2-trifluoro-1-(4-piperidin-4-ylphenyl)ethyl]-L-leucinamide;
N1-(cyanomethyl)-N2-{2,2,2-trifluoro-1-[4-(4-pyridin-2-ylpiperazin-1-yl)phenyl]ethyl}-L-leucinamide;
N2-[1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N-1-(cyanomethyl)-3-cyclopropylalaninamide;
N1-(cyanomethyl)-3-cyclopropyl-N2-[2,2,2-trifluoro-1-(4-pyridin-4-ylphenyl)ethyl] alaninamide;
N1-(cyanomethyl)-N2-[2,2,2-trifluoro-1-(4′-pyridin-4-yl-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;
N1-(cyanomethyl)-N2-[(1R)-2,2,2-trifluoro-1-(1,3-thiazol-2-yl)ethyl]-L-leucinamide;
N1-(cyanomethyl)-N2-[(1S)-2,2,2-trifluoro-1-(4′-methoxy-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;
N1-(cyanomethyl)-N2-[(1S)-2,2,2-trifluoro-1-(4-methoxyphenyl)ethyl]-L-leucinamide;
N1-(cyanomethyl)-N2-[(1S)-2,2,2-trifluoro-1-(4′-pyridin-4-yl-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;
N2-[(1S)-1-(4′-bromo-1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-N1-(cyanomethyl)-L-leucinamide;
N2-{(1S)-1-[4-(4-chloropyridin-3-yl)phenyl]-2,2,2-trifluoroethyl}-N1-(cyanomethyl)-L-leucinamide;
N2-{(1S)-1-[4′-(acetylamino)-2′-methyl-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-N-(cyanomethyl)-L-leucinamide;
N2-[(1S)-1-(1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-N1-(cyanomethyl)-L-leucinamide;
N1-(cyanomethyl)-N2-{(1S)-2,2,2-trifluoro-1-[4-(6-methoxypyridin-3-yl)phenyl]ethyl}-L-leucinamide;
N1-(cyanomethyl)-N2-{(1S)-2,2,2-trifluoro-1-[4-(6-methoxypyridin-2-yl)phenyl]ethyl}-L-leucinamide;
N2-[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N1-(cyanomethyl)-3-(1-methylcyclopropyl)-L-alaninamide;
N1-(cyanomethyl)-3-(1-methylcyclopropyl)-N2-{(1S)-2,2,2-trifluoro-1-[4′-(methylthio)-1,1′-biphenyl-4-yl]ethyl}-L-alaninamide;
N1-(cyanomethyl)-N2-[(1S)-2,2,2-trifluoro-1-(4′-methyl-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;
N1-(cyanomethyl)-N2-{(1S)-2,2,2-trifluoro-1-[4′-(hydroxymethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
N2-[1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N1-(cyanomethyl)-D-leucinamide;
N1-(cyanomethyl)-N2-{2,2,2-trifluoro-1-[4′-(morpholin-4-ylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-D-leucinamide;
N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-{4′-[(methylamino)sulfonyl]-1,1′-biphenyl-4-yl}ethyl)-D-leucinamide;
N1-(cyanomethyl)-N2-{(1R)-2,2,2-trifluoro-1-[4-(1-oxidopyridin-4-yl)phenyl]ethyl}-L-leucinamide;
N1-(cyanomethyl)-N2-{2,2,2-trifluoro-1-[4-(1-oxidopyridin-4-yl)phenyl]ethyl}-L-leucinamide;
N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-{4-[6-(1-hydroxy-1-methylethyl)-1-oxidopyridin-3-yl]phenyl}ethyl)-L-leucinamide;
N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-{4-[2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-yl]phenyl}ethyl)-L-leucinamide;
N2-[1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N1-(1-cyanocyclopropyl)-L-leucinamide;
N1-(cyanomethyl)-N2-[2,2,2-trifluoro-1-(4-piperazin-1-ylphenyl)ethyl]-L-leucinamide;
N2-{1-[3′-(acetylamino)-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-N1-(cyanomethyl)-L-leucinamide;
N1-(cyanomethyl)-N2-{2,2,2-trifluoro-1-[4-(4-propylpiperazin-1-yl)phenyl]ethyl}-L-leucinamide;
N1-(cyanomethyl)-N2-[(1S)-2,2,2-trifluoro-1-(4-{3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}phenyl)ethyl]-L-leucinamide;
N1-(cyanomethyl)-N2-{(1S)-2,2,2-trifluoro-1-[4-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]ethyl}-L-leucinamide;
N2-((1S)-1-{4-[3-(5-bromopyridin-3-yl)-1,2,4-oxadiazol-5-yl]phenyl}-2,2,2-trifluoroethyl)-N1-(cyanomethyl)-L-leucinamide;
N2-{(1S)-1-[4-(4-bromo-1,3-thiazol-2-yl)phenyl]-2,2,2-trifluoroethyl}-N1-(cyanomethyl)-L-leucinamide;
N1-(cyanomethyl)-N2-[(1S)-1-(4-cyanophenyl)-2,2,2-trifluoroethyl]-L-leucinamide;
N1-(cyanomethyl)-N2-[(1S)-1-(4-ethynylphenyl)-2,2,2-trifluoroethyl]-L-leucinamide;
N1-(cyanomethyl)-N2-[(1S)-2,2,2-trifluoro-1-(2′-fluoro-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;
N1-(cyanomethyl)-N2-{(1S)-2,2,2-trifluoro-1-[4-(1,3-thiazol-2-yl)phenyl]ethyl}-L-leucinamide;
N1-(cyanomethyl)-N2-{2,2,2-trifluoro-1-[4′-(methylthio)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
N1-(cyanomethyl)-N2-{1-[4′-(dimethylamino)-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-L-leucinamide;
N2-{(1S)-1-[4-(5-chloropyridin-2-yl)phenyl]-2,2,2-trifluoroethyl}-N1-(cyanomethyl)-L-leucinamide;
N2-{(1S)-1-[3′-(aminosulfonyl)-4′-bromo-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-N1-(cyanomethyl)-L-leucinamide;
N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-{4-[2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-yl]phenyl)ethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-N2-[(1S)-2,2,2-trifluoro-1-(4-methylphenyl)ethyl]-L-leucinamide;
N1-(1-cyanocyclopropyl)-N2-{(1S)-2,2,2-trifluoro-1-[4-(1H-pyrazol-3-yl)phenyl]ethyl}-L-leucinamide;
N2-(1-cyanocyclopropyl)-N-{2(1S)-2,2,2-trifluoro-1-[4-(2-methyl-1,3-oxazol-4-yl)phenyl]ethyl}-L-leucinamide;
N1-(cyanomethyl)-N2-[(1S)-2,2,2-trifluoro-1-(4-pyrazin-2-ylphenyl)ethyl]-L-leucinamide;
N1-(cyanomethyl)-N2-{(1S)-2,2,2-trifluoro-1-[4-(2-methylpyridin-4-yl)phenyl]ethyl}-L-leucinamide;
N1-(cyanomethyl)-N2-{(1S)-2,2,2-trifluoro-1-[4-(4-methylpyridin-3-yl)phenyl]ethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-N2-{(1S)-2,2,2-trifluoro-1-[4-(1H-pyrazol-4-yl)phenyl]ethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-N2-[(1S)-2,2,2-trifluoro-1-(4-pyridin-4-ylphenyl)ethyl]-L-leucinamide;
N1-(1-cyanocyclopropyl)-N2-[(1S)-2,2,2-trifluoro-1-(3′-fluoro-4′-methyl-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;
N1-(1-cyanocyclopropyl)-N2-((1S)-2,2,2-trifluoro-1-{5-[4-(1-hydroxy-1-methylethyl)phenyl]pyridin-2-yl}ethyl)-L-leucinamide;
N1-(cyanomethyl)-N2-{(1S)-2,2,3,3,3-pentafluoro-1-[4′-(1-hydroxy-1-methylethyl)-1,1′-biphenyl-4-yl]propyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-N2-[(1S)-2,2,3,3,3-pentafluoro-1-(4′-methyl-1,1′-biphenyl-4-yl)propyl]-L-leucinamide;
N1-(cyanomethyl)-N2-{(1S)-2,2,3,3,3-pentafluoro-1-[4-(6-methoxypyridin-3-yl)phenyl]propyl}-L-leucinamide;
N1-(cyanomethyl)-N2-[(1S)-2,2,3,3,3-pentafluoro-1-(2′-fluoro-1,1′-biphenyl-4-yl)propyl]-L-leucinamide;
N2-{(1S)-1-[3′-(aminosulfonyl)-4′-methoxy-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-N1-(1-cyanocyclopropyl)-L-leucinamide;
N1-(1-cyanocyclopropyl)-N2-{2(1S)-2,2,2-trifluoro-1-[4-(6-methoxypyridin-3-yl)phenyl]ethyl}-L-leucinamide;
N1-(cyanomethyl)-N-{(1S)-2,2,3,3,3-pentafluoro-1-[4-(5-methylpyridin-2-yl)phenyl]propyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-N2-{(1S)-2,2,2-trifluoro-1-[4-(5-methylpyridin-2-yl)phenyl]ethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-N-{(1S)-2,2,2-trifluoro-1-[5-(1H-pyrazol-3-yl)pyridin-2-yl]ethyl}-L-leucinamide;
N2-[(1S)-1-(1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-N1-(1-cyanocyclopropyl)-L-leucinamide;
N2-{(1S)-1-[4′-(aminosulfonyl)-1,1′-biphenyl-4-yl]-2,2,3,3,3-pentafluoropropyl}-N1-(1-cyanocyclopropyl)-L-leucinamide;
N1-(1-cyanocyclopropyl)-N2-{(1S)-1-[4-(1-ethoxyvinyl)phenyl]-2,2,2-trifluoroethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-N2-[(1S)-2,2,2-trifluoro-1-(4-isopropylphenyl)ethyl]-L-leucinamide;
N1-(1-cyanocyclopropyl)-N 2-[(1S)-2,2,2-trifluoro-1-phenylethyl]-L-leucinamide;
N1-(1-cyanocyclopropyl)-N2-{(1S)-2,2,2-trifluoro-1-[4-(1-hydroxy-1-methylethyl)phenyl]ethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-N2-{(1S)-2,2,2-trifluoro-1-[4-(1-methylcyclopropyl)phenyl]ethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-N2-[(1S)-2,2,2-trifluoro-1-(2′,4′,6′-trimethyl-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;
N2-[(1S)-1-(6-chloropyridin-3-yl)-2,2,2-trifluoroethyl]-N1-(1-cyanocyclopropyl)-L-leucinamide;
N1-(1-cyanocyclopropyl)-N2-((1S)-2,2,2-trifluoro-1-{5-[4-(1-hydroxyethyl)phenyl]pyridin-2-yl}ethyl)-L-leucinamide;
N2-[(1S)-1-(1,1′-biphenyl-4-yl)-2,2,3,3,3-pentafluoropropyl]-N1-(cyanomethyl)-L-leucinamide;
N2-[(1S)-1-(1,1′-biphenyl-4-yl)-2,2,3,3,3-pentafluoropropyl]-N1-(1-cyanocyclopropyl)-L-leucinamide;
N2-benzyl-2,2,2-trifluoroethyl)-N1-(1-cyanocyclopropyl)-L-leucinamide;
N2-[(1S)-1-(4-tert-butylphenyl)-2,2,2-trifluoroethyl]-N1-(1-cyanocyclopropyl)-L-leucinamide;
N2-[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N1-(cyanomethyl)-4-methyl-L-leucinamide;
N2-[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N1-(1-cyanocyclopropyl)-4-methyl-L-leucinamide;
N2-(1-cyanocyclopropyl)-N2-((1S)-2,2,2-trifluoro-1-{4-[2-(1H-pyrazol-4-yl)-1,3-thiazol-4-yl]phenyl}ethyl)-L-leucinamide;
N2-(1-cyanocyclopropyl)-N-{(1S)-2,2,2-trifluoro-1-[4-(2-methyl-1,3-thiazol-4-yl)phenyl]ethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-N2-{2(1S)-2,2,2-trifluoro-1-[4-(2-methylpyridin-4-yl)phenyl]ethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-N2-{(1S)-2,2,2-trifluoro-1-[4-(2-methylpyridin-3-yl)phenyl]ethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-N-{(1S)-2,2,2-trifluoro-1-[4-(6-methylpyridin-2-yl)phenyl]ethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4-(1H-pyrazol-3-yl)phenyl]ethyl}-L-leucinamide;
N2-[(1S)-1-(4-bromophenyl)-2,2,3,3,3-pentafluoropropyl]-N1-(1-cyanocyclopropyl)-L-leucinamide;
N1-(cyanomethyl)-N2-{(1S)-2,2,3,3,3-pentafluoro-1-[4-(6-methoxypyridin-2-yl)phenyl]propyl}-L-leucinamide;
N2-[(1S)-1-(5-bromopyridin-2-yl)-2,2,2-trifluoroethyl]-N1-(cyanomethyl)-L-leucinamide;
N1-(1-cyanocyclopropyl)-N2 {(S)-2,2,2-trifluoro-1-[4′-(−hydroxy-1-methylethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
N1-(cyanomethyl)-N2-[(1S)-2,2,2-trifluoro-1-(6′-methyl-3,3′-bipyridin-6-yl)ethyl]-L-leucinamide;
N1-(1-cyanocyclopropyl)-N2-{(1S)-2,2,2-trifluoro-1-[4-(6-methoxypyridin-2-yl)phenyl]ethyl}-L-leucinamide;
(4S)-N1-(cyanomethyl)-5,5,5-trifluoro-N2-{(1S)-2,2,2-trifluoro-1-[4′-(methylthio)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
(4S)-N1-(1-cyanocyclopropyl)-5,5,5-trifluoro-N2-{(1S)-2,2,2-trifluoro-1-[4′-(methylthio)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
(4S)-N2-[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N-(cyanomethyl)-5,5,5-trifluoro-L-leucinamide;
(4S)-N2-[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N1-(1-cyanocyclopropyl)-5,5,5-trifluoro-L-leucinamide;
N2-{(1S)-1-[4-(6-aminopyridin-3-yl)phenyl]-2,2,2-trifluoroethyl}-N1-(cyanomethyl)-L-leucinamide;
N2-[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N1-(1-cyanocyclopropyl)-4-fluoro-L-leucinamide;
N1-(cyanomethyl)-N-2{(1S)-2,2,3,3,3-pentafluoro-1-[4-(6-methylpyridin-3-yl)phenyl]propyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-N2-{(1S)-2,2,3,3,3-pentafluoro-1-[4-(6-methylpyridin-3-yl)phenyl]propyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-N2-{(1S)-2,2,2-trifluoro-1-[4-(6-methylpyridin-3-yl)phenyl]ethyl}-L-leucinamide;
N1-(cyanomethyl)-N2-{(1S)-2,2,2-trifluoro-1-[4′-(1-hydroxyethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
N1-(cyanomethyl)-N2-{(1S)-2,2,2-trifluoro-1-[4′-(2,2,2-trifluoro-1-hydroxyethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-N-{(1S)-2,2,3,3,3-pentafluoro-1-[4′-(methylthio)-1,1′-biphenyl-4-yl]propyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-N2-{(1S)-2,2,3,3,3-pentafluoro-1-[4′-(1-hydroxy-1-methylethyl)-1,1′-biphenyl-4-yl]propyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-N2-{(1S)-2,2,3,3,3-pentafluoro-1-[4-(6-methoxypyridin-2-yl)phenyl]propyl}-L-leucinamide;
N1-(cyanomethyl)-N2-[(1S)-2,2,3,3,3-pentafluoro-1-(4′-methyl-1,1′-biphenyl-4-yl)propyl]-L-leucinamide;
N1-(cyanomethyl)-N2-{(1S)-2,2,3,3,3-pentafluoro-1-[4-(1,3-thiazol-2-yl)phenyl]propyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-N2-[(1S)-1-(4-ethynylphenyl)-2,2,3,3,3-pentafluoropropyl]-L-leucinamide;
N1-(cyanomethyl)-N2-{(1S)-2,2,2-trifluoro-1-[4-(5-methyl-1,3-thiazol-2-yl)phenyl]ethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-N2-{(1S)-2,2,2-trifluoro-1-[4-(1,3-thiazol-2-yl)phenyl]ethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-N2-{(1S)-2,2,2-trifluoro-1-[4-(5-methyl-1,3-thiazol-2-yl)phenyl]ethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-N2-{(1S)-2,2,2-trifluoro-1-[4-(4-methyl-1,3-thiazol-2-yl)phenyl]ethyl}-L-leucinamide;
N1-(cyanomethyl)-N2-{(1S)-2,2,2-trifluoro-1-[4-(4-methyl-1,3-thiazol-2-yl)phenyl]ethyl}-L-leucinamide;
N1-(cyanomethyl)-N2-{(1S)-1-[4-(4,5-dimethyl-1,3-thiazol-2-yl)phenyl]-2,2,2-trifluoroethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-[(1S)-2,2,2-trifluoro-1-(4-pyridin-3-ylphenyl)ethyl]-L-leucinamide;
N2-[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N1-(cyanomethyl)-L-alaninamide;
N2-{(1S)-1-[4′-(aminosulfonyl)-1,1′-biphenyl-4-yl]-2,2,3,3,3-pentafluoropropyl}-N1-(cyanomethyl)-L-leucinamide;
N2-{(1S)-1-[4′-(aminosulfonyl)-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-N1-(1-cyanocyclopropyl)-4-fluoro-L-leucinamide;
N2-[1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N1-(cyanomethyl)-L-norvalinamide;
N2-[1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N1-(cyanomethyl)-5,5,5-trifluoro-L-norvalinamide;
N2-[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N1-(1-cyanocyclopropyl)-L-norvalinamide
N2-{(1S)-1-[4′-(aminosulfonyl)-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-N1-(1-cyanocyclopropyl)-L-norvalinamide;
N1-(1-cyanocyclopropyl)-N2-{(1S)-2,2,2-trifluoro-1-[4-(2-methylpyridin-4-yl)phenyl]ethyl}-L-norvalinamide;
N1-(1-cyanocyclopropyl)-N-{2(1S)-2,2,2-trifluoro-1-[4-(1H-pyrazol-3-yl)phenyl]ethyl}-L-norvalinamide;
N1-(1-cyanocyclopropyl)-N2-{((S)-2,2,2-trifluoro-1-[4′-(1-hydroxy-1-methylethyl)-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;
N1-(1-cyanocyclopropyl)-N2-{(1S)-2,2,2-trifluoro-1-[4-(5-methylpyridin-2-yl)phenyl]ethyl}-L-norvalinamide;
(2S)-2-[(S)-1-(2′,4′-Difluorobiphenyl-4-yl)-2,2,2-trifluoroethylamino]-pentanoic acid (1-cyanocyclopropyl)-amide;
(2S)-2-[(S)-1-(3′,4′-Difluorobiphenyl-4-yl)-2,2,2-trifluoroethylamino]-pentanoic acid (1-cyanocyclopropyl)-amide;
(2S)-2-[(S)-1-(3′-Chloro-4′-fluorobiphenyl-4-yl)-2,2,2-trifluoroethylamino]-pentanoic acid (1-cyano-cyclopropyl)-amide;
(2S)-2-[(S)-2,2,2-Trifluoro-1-(4′-methanesulfonylamino-biphenyl-4-yl)-ethylamino]-pentanoic acid (1-cyano-cyclopropyl)-amide;
N1-(1-cyanocyclopropyl)-N2-{(1S)-2,2,2-trifluoro-11-[4′-chloro-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;
N1-(1-cyanocyclopropyl)-N2-{(1S)-2,2,2-trifluoro-1-[4′-chloro-3′-methyl-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;
N1-(1-cyanocyclopropyl)-N {(1S)-2,2,2-trifluoro-1-[4′-chloro-2′-methyl-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;
(2S)-2-[(S)-2,2,2-Trifluoro-1-(3′-methanesulfonylamino-biphenyl-4-yl)-ethylamino]-pentanoic acid (1-cyano-cyclopropyl)-amide;
N1-(1-cyanocyclopropyl)-N2-{(1S)-2,2,2-trifluoro-1-[4′-fluoro-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;
N1-(1-cyanocyclopropyl)-N2-{(1S)-2,2,2-trifluoro-1-[4′-fluoro-3′-methyl-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;
N1-(1-cyanocyclopropyl)-N2-{(1S)-2,2,2-trifluoro-1-[3′-fluoro-4′-methyl-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;
N1-(1-cyanocyclopropyl)-N2-{(1S)-2,2,2-trifluoro-1-[4′-trifluoromethoxy-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;
(2S)-2-[(S)-2,2,2-Trifluoro-1-(4′-methylbiphenyl-4-yl)-ethylamino]-pentanoic acid (1-cyanocyclopropyl)-amide;
(2S)-2-[(S)-1-(4′-Cyanobiphenyl-4-yl)-2,2,2-trifluoroethylamino]-pentanoic acid (1-cyanocyclopropyl)-amide;
N1-(1-cyanocyclopropyl)-N2-{(1S)-2,2,2-trifluoro-1-[4′-methoxy-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;
N1-(1-cyanocyclopropyl)-N2-{(1S)-2,2,2-trifluoro-1-[4′-(methoxycarbonyl)-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;
(2S)-2-[(S)-2,2,2-Trifluoro-1-(4′-trifluoromethyl-biphenyl-4-yl)-ethylamino]-pentanoic acid (1-cyano-cyclopropyl)-amide;
(2S)-2-[(S)-2,2,2-Trifluoro-1-(2′-trifluoromethyl-biphenyl-4-yl)-ethylamino]-pentanoic acid (1-cyano-cyclopropyl)-amide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfinyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[2′-(1-hydroxy-1-methylethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
N2-[(1S)-1-(1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-N1-(1-cyanocyclopropyl)-4-fluoro-L-leucinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[3′-(1-hydroxyethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-[(1S)-2,2,2-trifluoro-1-(4′-methyl-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[3′-(1-hydroxy-1-methylethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4′-(1-hydroxyethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2 {(S)-2,2,2-trifluoro-1-[2′-(−hydroxyethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4′-(1-hydroxy-1-methylethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[2′-(1-hydroxy-1-methylethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N1-[(1S)-2,2,2-trifluoro-1-(4-{6-[(methylsulfonyl)amino]pyridin-3-yl}phenyl)ethyl]-L-leucinamide;
N1-(cyanomethyl)-4-fluoro-N2-[(1S)-2,2,2-trifluoro-1-(4-{6-[(methylsulfonyl)amino]pyridin-3-yl}phenyl)ethyl]-L-leucinamide;
N1-(1-cyanobutyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(S)-2,2,2-trifluoro-1-[4′-(methylsulfinyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-4,4-difluoro-N2-{(1S)-2,2,2-trifluoro-1-[4′-(methylthio)-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfinyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-N2-{(1S)-2,2,2-trifluoro-1-[4′-(1-hydroxyethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
N2-[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N1-(1-cyanocyclopropyl)-4,4-difluoro-L-norvalinamide;
N1-(1-cyanocyclopropyl)-4,4-difluoro-N2-{(1S)-2,2,2-trifluoro-1-[4′-(methylthio)-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-((1S)-2,2,2-trifluoro-1-{4-[6-(1-hydroxy-1-methylethyl)-5-methylpyridin-3-yl]phenyl}ethyl)-L-leucinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-[(1S)-2,2,2-trifluoro-1-(4′-fluoro-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N-{(1S)-2,2,2-trifluoro-1-[4-(6-methylpyridin-3-yl)phenyl]ethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4′-(methylthio)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4′-(1-hydroxy-1-methylethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
N2-[(S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N1-(cyanomethyl)-4,4-difluoro-L-norvalinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-((1S)-2,2,2-trifluoro-1-{4′-[(1S)-1-hydroxyethyl]-1,1′-biphenyl-4-yl}ethyl)-L-leucinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-((1S)-2,2,2-trifluoro-1-{4′-[(1R)-1-hydroxyethyl]-1,1′-biphenyl-4-yl}ethyl)-L-leucinamide;
N1-(cyanomethyl)-4,4-difluoro-N2-{(1S)-2,2,2-trifluoro-1-[4′-(methylthio)-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4-(5-methyl-1,3-thiazol-2-yl)phenyl]ethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-[(1S)-2,2,2-trifluoro-1-(4′-methyl-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;
N2-[(1S)-1-(1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-N1-(1-cyanocyclopropyl)-4-fluoro-L-leucinamide;
N2-{(1S)-1-[4-(5-chloropyridin-2-yl)phenyl]-2,2,2-trifluoroethyl}-N1-(1-cyanocyclopropyl)-4-fluoro-L-leucinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-[(1S)-2,2,2-trifluoro-1-(4-pyridin-4-ylphenyl)ethyl]-L-leucinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-((1S)-2,2,2-trifluoro-1-{4′-[(methylsulfonyl)amino]-1,1′-biphenyl-4-yl}ethyl)-L-leucinamide;
N2-[(1S)-1-(4-bromophenyl)-2,2-difluoroethyl]-N1-(1-cyanocyclopropyl)-L-leucinamide;
N2-(1-cyanocyclopropyl)-N-{2(1S)-2,2-difluoro-1-[4′-(methylthio)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-[(1S)-2,2,2-trifluoro-1-(4-pyrimidin-5-ylphenyl)ethyl]-L-leucinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[3′-(1-hydroxyethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-N2-{(1S)-1-[4-(3,5-dimethylisoxazol-4-yl)phenyl]-2,2,2-trifluoroethyl}-4-fluoro-L-leucinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfinyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-N-{(1S)-2,2,2-trifluoro-1-[4′-(1-hydroxyethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
N2-[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N1-(1-cyanocyclopropyl)-4,4-difluoro-L-norvalinamide;
N1-(1-cyanocyclopropyl)-4,4-difluoro-N2-{(1S)-2,2,2-trifluoro-1-[4′-(methylthio)-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-((1S)-2,2,2-trifluoro-1-{4-[6-(1-hydroxy-1-methylethyl)-5-methylpyridin-3-yl]phenyl}ethyl)-L-leucinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N-[(1S)-2,2,2-trifluoro-1-(4′-fluoro-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4-(6-methylpyridin-3-yl)phenyl]ethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4′-(methylthio)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-{((S)-2,2,2-trifluoro-1-[4′-(1-hydroxy-1-methylethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
N2-[(1S)-1-(4-bromophenyl)-2,2,2-trifluoroethyl]-N1-(cyanomethyl)-4,4-difluoro-L-norvalinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-((1S)-2,2,2-trifluoro-1-{4′-[(1S)-1-hydroxyethyl]-1,1′-biphenyl-4-yl}ethyl)-L-leucinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-((1S)-2,2,2-trifluoro-1-{4′-[(1R)-1-hydroxyethyl]-1,1′-biphenyl-4-yl}ethyl)-L-leucinamide;
N1-(cyanomethyl)-4,4-difluoro-N2-{(1S)-2,2,2-trifluoro-1-[4′-(methylthio)-1,1′-biphenyl-4-yl]ethyl}-L-norvalinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4-(5-methyl-1,3-thiazol-2-yl)phenyl]ethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-[(1S)-2,2,2-trifluoro-1-(4′-methyl-1,1′-biphenyl-4-yl)ethyl]-L-leucinamide;
N2-[(1S)-1-(1,1′-biphenyl-4-yl)-2,2,2-trifluoroethyl]-N1-(1-cyanocyclopropyl)-4-fluoro-L-leucinamide;
N2-{(1S)-1-[4-(5-chloropyridin-2-yl)phenyl]-2,2,2-trifluoroethyl}-N1-(1-cyanocyclopropyl)-4-fluoro-L-leucinamide;
N2-(1-cyanocyclopropyl)-4-fluoro-N2-[(1S)-2,2,2-trifluoro-1-(4-pyridin-4-ylphenyl)ethyl]-L-leucinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-((1S)-2,2,2-trifluoro-1-{4′-[(methylsulfonyl)amino]-1,1′-biphenyl-4-yl}ethyl)-L-leucinamide;
N2-[(S)-1-(4-bromophenyl)-2,2-difluoroethyl]-N1-(1-cyanocyclopropyl)-L-leucinamide;
N1-(1-cyanocyclopropyl)-N2-{(1S)-2,2-difluoro-1-[4′-(methylthio)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2 [(S)-2,2,2-trifluoro-1-(4-pyrimidin-5-ylphenyl)ethyl]-L-leucinamide;
N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[3′-(1-hydroxyethyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide;
N2-(1-cyanocyclopropyl)-N-{(1S)-1-[4-(3,5-dimethylisoxazol-4-yl)phenyl]-2,2,2-trifluoroethyl}-4-fluoro-L-leucinamide;
and the pharmaceutically acceptable salts, stereoisomers and N-oxide derivatives thereof.

### Claim 10

(canceled)

### Claim 11

N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4′-(methylsulfinyl)-1,1′-biphenyl-4-yl]ethyl}-L-leucinamide or a pharmaceutically acceptable salt thereof.

### Claim 12

(canceled)

### Claim 13

N2{(1S)-1-[4′-(aminosulfonyl)-1,1′-biphenyl-4-yl]-2,2,2-trifluoroethyl}-N1(cyanomethyl)-L-leucinamide or a pharmaceutically acceptable salt thereof.

### Claim 14 (depends on 1)

A pharmaceutical composition comprising a compound according to claim 1 and a pharmaceutically acceptable carrier.

### Claim 15 (depends on 1)

A pharmaceutical composition made by combining a compound according to claim 1 and a pharmaceutically acceptable carrier.

### Claim 16 (depends on 1)

A process for making a pharmaceutical composition comprising combining a compound according to claim 1 and a pharmaceutically acceptable carrier.

### Claim at position 17

17-28. (canceled)
